Study Information

Title: A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer External
Status: Recruiting participants
Conditions: Non Small Cell Lung Cancer
Interventions: Drug: COMBINED PF-02341066 AND PF-00299804; Drug: PF-00299804 FOLLOWED BY COMBINED PF-02341066 AND PF-00299804
Health Topics: Adenocarcinoma of the Lung, Lung Cancer Overview, Squamous cell carcinoma of the lung

Contact Information


Pfizer Investigational Site
Boston, MA 02114
Pfizer Investigational Site
Boston, MA 02115
Pfizer Investigational Site
Boston, MA 02215